Trials
3 active
5 in total · 1 in the EU
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Bel-sar via suprachoroidal administration followed by laser application.”In the company’s words, NCT06007690 on ClinicalTrials.gov
- Tested for
- Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma, Eye Cancer, Primary Cancer, Non-muscle-invasive Bladder Cancer, NMIBC and 4 more
- Main trialPhase 3
- “The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma (CM).”In the company’s words, NCT06007690 on ClinicalTrials.gov
- Other names
- Bel-sar · belzupacap sarotalocan
Other drugs for Choroidal Melanoma
- DarovasertibIDEAYA Biosciences · Phase 3
- RP2Replimune, Inc. · Phase 2/3
- Melphalan/HDSDelcath Systems Inc. · Phase 3
- EB-DTKN-401Beijing Biotech · Phase 1/2
- DYP688Novartis Pharmaceuticals · Phase 1/2
- RoginolisibiOnctura · Phase 2
Coming up3
- 30 NovPhase 2 trial completes · ClinicalTrials.gov
- Mar 2027Phase 1 trial completes · ClinicalTrials.gov
- 15 Nov 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 15 Nov 2027 | A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma | |
| Phase 2Recruiting | 30 Nov 2026 | Suprachoroidal Administration in Subjects With Metastases to the Choroid | |
| Phase 1Active, not recruiting | Mar 2027 | A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer | |
| Phase 2Completed | 22 Apr 2024 | Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma | |
| Phase 1/2Completed | 26 Jan 2021 | Study in Subjects With Small Primary Choroidal Melanoma |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026